Up
2004P-0015:
DENY APPROVAL OF ANY NEW DRUG APPLICATION ( NDA ) FOR RECOMBINANT
SALMON CALCITONIN (RSCT ) NASAL SPRAY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
| CP1
|
| 01/09/2004
|
| 01/09/2004
|
| Drug Industry
|
| Buc & Beardsley
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Nancy L. Buc
|
|
|
| ACK1
|
| 01/09/2004
|
| 01/09/2004
|
| Government
|
| HFA-305 to Buc &
Beardsley
|
|
|
|
|
|
|
| doc
|
|
|
|
| Signature:
|
| Jennie C. Butler
|
|
|
| LET1
|
| 07/08/2004
|
| 07/08/2004
|
| Federal
Government
|
| HFD-005 to Buc &
Beardsley
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Jane A. Axelrad
|
|
|
|
|
| EMC1
|
| 01/25/2005
|
| 01/25/2005
|
| Private Industry
|
| Investor in Unigene,
Inc.
|
|
|
|
|
|
|
|
|
|
|
|
| Signature:
|
| Douglas Goble
|
|
|
| EMC2
|
| 04/11/2005
|
| 04/11/2005
|
| Drug Industry
|
| Unigene Laboratories,
Inc. (Unigene)
|
|
|
|
|
|
|
| 01,
02
|
|
|
|
|
| Signature:
|
| Ronald S. Levy, PhD
|
|
| RC1
|
| 04/27/2005
|
| 04/27/2005
|
| Private Industry
|
| Buc & Beardsley
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Nancy L. Buc
| |
|
| PDN1
|
| 08/16/2005
|
| 08/16/2005
|
| Federal Government
|
| HFD-001 to Buc &
Beardsley
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Steven K. Galson, MD, MPH
|
|
Top
| Up
Page last updated
October 12, 2005
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |